Press coverage about Aetna (NYSE:AET) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aetna earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave news stories about the company an impact score of 45.8936707057985 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the media stories that may have impacted Accern’s rankings:
- Less Risky stock is less profitable: Aetna Inc. (AET) – Wallstreet Investorplace (wallstreetinvestorplace.com)
- CVS, Aetna Shareholders Back $69 Billion Deal – Hartford Courant (courant.com)
- CVS and Aetna Shareholders Approve Merger (financialbuzz.com)
- CVS Health (CVS) Shareholders Approve Aetna (AET) Deal (streetinsider.com)
Aetna (NYSE:AET) traded down $0.82 during trading on Wednesday, hitting $176.62. The stock had a trading volume of 1,885,774 shares, compared to its average volume of 2,540,000. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.65 and a quick ratio of 0.65. The firm has a market cap of $57,740.00, a PE ratio of 29.19, a price-to-earnings-growth ratio of 1.43 and a beta of 0.65. Aetna has a 52-week low of $124.84 and a 52-week high of $194.40.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Thursday, April 12th will be given a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, April 11th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. Aetna’s payout ratio is 33.06%.
Several analysts have issued reports on the company. Piper Jaffray Companies reaffirmed a “buy” rating and set a $212.00 target price on shares of Aetna in a research report on Tuesday, January 30th. ValuEngine raised Aetna from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Credit Suisse Group increased their target price on Aetna from $200.00 to $208.00 and gave the company a “neutral” rating in a research report on Wednesday, January 31st. Citigroup cut Aetna from a “buy” rating to a “neutral” rating and increased their target price for the company from $187.89 to $212.00 in a research report on Wednesday, January 31st. Finally, Cowen reaffirmed a “buy” rating and set a $212.00 target price on shares of Aetna in a research report on Tuesday, January 30th. Nine investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $189.50.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.